EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genotype II Live‐Attenuated ASFV Vaccine Bearing 24 Genes Deletion in 3 Independent Regions Is Able to Provide Complete Protection Against Homologous Lethal Challenge

Fan Xu, Wen Dang, Yu Du, Tao Li, Huanan Liu, Zhengwang Shi, Hong Tian, Jijun He, Haixue Zheng iD

The FASEB Journal · 15.09.2026 · 40 (17)

DOI: 10.1096/fj.202601491r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 02.09.2026. Verfasst von Fan Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Instit…. Hauptthemen laut MEDLINE: African Swine Fever Virus, African Swine Fever, Viral Vaccines, Gene Deletion. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Project of the National Natural Science Foundation of China, MOST | National Key Research and Development Program of China (NKPs), Innovation Program of Chinese Academy of Agricultural Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

African swine fever (ASF) is an acute, febrile, and highly contagious infectious disease of swine with the etiological agent of African swine fever virus (ASFV). The mortality rate of virulent strains is as high as 100%. Strengthening biosafety is so far the most effective way to prevent and control ASF. Therefore, it is urgent to develop a safe and effective vaccine. In this study, a Genotype II live‐attenuated ASF vaccine bearing 24 genes deletion in 3 independent regions was constructed based on the highly virulent Eurasian strain ASFV CN/GS 2018 backbone. The resulting mutant ASFV‐Δ24 is characterized by complete deletion of 24 genes distributed in 3 genomic positions of 852 to 11 468, 19 732 to 22 929, and 179 519 to 180 617, among which MGF100 and whole MGF300 families are pioneeringly removed. The ASFV‐Δ24 displayed a delayed and reduced replication kinetics as well as aberrant icosahedral empty particles devoid of a nucleoid when compared to the parental virus. Animal experiments showed that ASFV‐Δ24 was completely attenuated in animals as evidenced by stable body temperature and no ASF‐compatible clinical signs in vaccinated pigs. The ASFV‐Δ24 could provide complete homologous protection against lethal challenge, as vaccinated pigs demonstrated boosted antibody response, transient but low levels of viremia in blood and virus titers in organs as well as almost undetectable viral shedding. Gene deletions in multiple regions are helpful for prevention of virulence reversion. These results indicate that ASFV‐Δ24 can be used as an effective and promising candidate vaccine to control the spread of ASFV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

African Swine Fever VirusAfrican Swine FeverViral VaccinesGene DeletionAnimalsVaccines, AttenuatedSwineGenotypeVirulenceAntibodies, ViralVirus Replication

Stichwörter der Autor:innen

African swine fever virushomologous protectionimmune protectionlive attenuated vaccinemulti‐gene family

Substanzen

Vaccines, AttenuatedViral VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.

ORCID-Profile: Haixue Zheng

Förderung

  • Project of the National Natural Science Foundation of China
  • MOST | National Key Research and Development Program of China (NKPs)
  • Innovation Program of Chinese Academy of Agricultural Sciences
  • Project of National Center of Technology Innovation for Pigs
  • China Agriculture Research System of Ministry of Finance and Ministry of Agriculture and Rural Affairs
  • Science and Technology Program of Gansu Province
  • National Key Research and Development Program of China

Zitieren

APA

Xu, F., Dang, W., Du, Y., Li, T., Liu, H., Shi, Z., Tian, H., He, J., & Zheng, H. (2026). Genotype II Live‐Attenuated ASFV Vaccine Bearing 24 Genes Deletion in 3 Independent Regions Is Able to Provide Complete Protection Against Homologous Lethal Challenge. The FASEB Journal, 40(17). https://doi.org/10.1096/fj.202601491r

Vancouver

Xu F, Dang W, Du Y, Li T, Liu H, Shi Z, et al. Genotype II Live‐Attenuated ASFV Vaccine Bearing 24 Genes Deletion in 3 Independent Regions Is Able to Provide Complete Protection Against Homologous Lethal Challenge. The FASEB Journal. 2026;40(17). doi:10.1096/fj.202601491r

BibTeX
@article{Xu2026,
  author = {Xu, Fan and Dang, Wen and Du, Yu and Li, Tao and Liu, Huanan and Shi, Zhengwang and Tian, Hong and He, Jijun and Zheng, Haixue},
  title = {Genotype II Live‐Attenuated ASFV Vaccine Bearing 24 Genes Deletion in 3 Independent Regions Is Able to Provide Complete Protection Against Homologous Lethal Challenge},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {17},
  doi = {10.1096/fj.202601491r}
}
Kostenlos starten →